 23andMe Holding Co. ME, 1.27 said Friday it agreed to pay 400 million for Lemonaid Health Inc., the on-demand platform for accessing medical care and pharmacy services, in a bid to add telemedicine and prescription drug delivery services. The purchase price includes 25 cash and 75 in shares of 23andMe Class A common stock. 